| Metric | შპს ვორლდ ფარმა | შპს ანშენ ფარმა | შპს Linema Pharm |
|---|---|---|---|
| Growth | |||
| Revenue | ₾4.5m₾2.5m | ₾1.8m₾2.2m | ₾3.9m₾1.6m |
| Revenue growth | 83.4% | -15.9% | 139.8% |
| Profitability | |||
| EBITDA | ₾1.8m₾933k | ₾611k₾355k | ₾1.2m₾465k |
| EBITDA margin | 39.6%38.0% | 33.4%16.3% | 31.0%28.7% |
| Net profit | ₾1.8m₾778k | ₾520k₾288k | |
| ₾1.2m-₾90k |
| Net margin | 39.6%31.6% | 28.4%13.2% | 31.0%-5.5% |
| Balance sheet | |||
| Total assets | ₾4.1m₾1.9m | ₾2.7m₾2.3m | ₾7.5m₾6.2m |
| Total equity | ₾3.3m₾1.5m | ₾2.7m₾2.2m | ₾6.4m₾5.4m |
| ROE | 54.8%52.7% | 19.2%13.1% | 18.9%-1.6% |